BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38677756)

  • 21. Serum squamous cell carcinoma antigen levels in invasive cervical cancer: prediction of response and recurrence.
    Rose PG; Baker S; Fournier L; Nelson BE; Hunter RE
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):942-6. PubMed ID: 8456907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implications of elevated pretreatment carcinoembryonic antigen in patients with advanced squamous cell carcinoma of the uterine cervix.
    Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Yang SN; Lin FJ
    Tumour Biol; 2008; 29(4):255-61. PubMed ID: 18781097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer.
    Esajas MD; Duk JM; de Bruijn HW; Aalders JG; Willemse PH; Sluiter W; Pras B; ten Hoor K; Hollema H; van der Zee AG
    J Clin Oncol; 2001 Oct; 19(19):3960-6. PubMed ID: 11579117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation Between Squamous Cell Carcinoma Antigen Level and the Clinicopathological Features of Early-Stage Cervical Squamous Cell Carcinoma and the Predictive Value of Squamous Cell Carcinoma Antigen Combined With Computed Tomography Scan for Lymph Node Metastasis.
    Xu D; Wang D; Wang S; Tian Y; Long Z; Ren X
    Int J Gynecol Cancer; 2017 Nov; 27(9):1935-1942. PubMed ID: 28914639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Application of 18F-FDG PET/CT in cervical cancer with elevated levels of serum squamous cell carcinoma antigen during the follow-up].
    Hu YY; Sun XR; Lin XP; Liang PY; Zhang X; Fan W
    Ai Zheng; 2009 Sep; 28(9):994-9. PubMed ID: 19728921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postreatment squamous cell carcinoma antigen as a survival prognostic factor in patients with locally advanced cervical cancer. A Spanish multicenter study. The SEGO Spain-GOG group.
    Benito V; Lubrano A; Pérez-Regadera JF; Torné A; Gil-Moreno A; Tejerizo-Garcia Á; Vergés R; Díaz-Feijoo B;
    Gynecol Oncol; 2021 Aug; 162(2):407-412. PubMed ID: 34119366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study.
    Li X; Zhou J; Huang K; Tang F; Zhou H; Wang S; Jia Y; Sun H; Ma D; Li S
    PLoS One; 2015; 10(4):e0122361. PubMed ID: 25860888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic utility of squamous cell carcinoma antigen in carcinoma of the cervix: association with pre- and posttreatment FDG-PET.
    Olsen JR; Dehdashti F; Siegel BA; Zighelboim I; Grigsby PW; Schwarz JK
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):772-7. PubMed ID: 20888130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The kinetic profile and clinical implication of SCC-Ag in squamous cervical cancer patients undergoing radical hysterectomy using the Simoa assay: a prospective observational study.
    Ye S; Sun X; Kang B; Wu F; Zheng Z; Xiang L; Lesénéchal M; Heskia F; Liang J; Yang H
    BMC Cancer; 2020 Feb; 20(1):138. PubMed ID: 32085736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels of cytokeratin 19 fragments in cervical cancer.
    Nasu K; Etoh Y; Yoshimatsu J; Matsu T; Narahara H; Miyakawa I
    Gynecol Obstet Invest; 1996; 42(4):267-70. PubMed ID: 8979101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Usefulness of the SCC, CEA, CYFRA 21.1, and CRP markers for the diagnosis and monitoring of cervical squamous cell carcinoma].
    Chmura A; Wojcieszek A; Mrochem J; Walaszek-Gruszka A; Deja R; Masłyk B; Bartnik W; Sodowski K
    Ginekol Pol; 2009 May; 80(5):361-6. PubMed ID: 19548456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Significance of Serum Squamous Cell Carcinoma Antigen for Patients with Recurrent Esophageal Squamous Cell Carcinoma.
    Kanie Y; Okamura A; Maruyama S; Sakamoto K; Fujiwara D; Kanamori J; Imamura Y; Watanabe M
    Ann Surg Oncol; 2021 Nov; 28(12):7990-7996. PubMed ID: 33839977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The curative role of radiotherapy in patients with isolated para-aortic node recurrence from cervical cancer and value of squamous cell carcinoma antigen for early detection.
    Ogino I; Nakayama H; Kitamura T; Okamoto N; Inoue T
    Int J Gynecol Cancer; 2005; 15(4):630-8. PubMed ID: 16014117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of pretreatment squamous cell carcinoma antigen level in locally advanced squamous cell carcinoma of the uterine cervix treated by radiotherapy.
    Ogino I; Nakayama H; Okamoto N; Kitamura T; Inoue T
    Int J Gynecol Cancer; 2006; 16(3):1094-100. PubMed ID: 16803491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix.
    Takeda M; Sakuragi N; Okamoto K; Todo Y; Minobe S; Nomura E; Negishi H; Oikawa M; Yamamoto R; Fujimoto S
    Acta Obstet Gynecol Scand; 2002 May; 81(5):451-7. PubMed ID: 12027820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of squamous cell carcinoma antigen in cancer of the human uterine cervix. Comparison with CEA and CA-125.
    Verlooy H; Devos P; Janssens J; Mortelmans L; Gerits M; Bonte J; De Roo M
    Gynecol Obstet Invest; 1991; 32(1):55-8. PubMed ID: 1765320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive factor of distant recurrence in locally advanced squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy.
    Hirakawa M; Nagai Y; Inamine M; Kamiyama K; Ogawa K; Toita T; Murayama S; Aoki Y
    Gynecol Oncol; 2008 Jan; 108(1):126-9. PubMed ID: 17936344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum levels of squamous cell carcinoma antigen and ovarian carcinoma antigen (CA 125) in patients with benign and malignant diseases of the uterine cervix.
    Gocze PM; Vahrson HW; Freeman DA
    Oncology; 1994; 51(5):430-4. PubMed ID: 8052484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix.
    de Bruijn HW; Duk JM; van der Zee AG; Pras E; Willemse PH; Boonstra H; Hollema H; Mourits MJ; de Vries EG; Aalders JG
    Tumour Biol; 1998; 19(6):505-16. PubMed ID: 9817980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical cancer.
    Davelaar EM; van de Lande J; von Mensdorff-Pouilly S; Blankenstein MA; Verheijen RH; Kenemans P
    Tumour Biol; 2008; 29(1):9-17. PubMed ID: 18497544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.